1380 Non-clinical results and design of first-in-human study for GIGA-564, a third-generation anti-CTLA-4 monoclonal antibody

• James L Gulley,
• Rong Deng,
• Carl Millward,
• Jason M Redman,
• Yao Chiang,
• Ariel Niedecken,
• Kacy Stadtmiller,
• Edward Garmey,
• Vincent Poon,
• Michael A Asensio,
• Janice Lansita,
• Kyle P Carter,
• Ellen K Wagner,
• Erica L Stone

Affiliations

James L Gulley

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Rong Deng

3RandD Q-Pharm Consulting, LLC, Pleasanton, CA, USA

Carl Millward

6Grifols, San Carlos, CA, USA

Jason M Redman

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Yao Chiang

2GigaGen, San Carlos, CA, USA

Ariel Niedecken

2GigaGen, San Carlos, CA, USA

Kacy Stadtmiller

2GigaGen, San Carlos, CA, USA

Edward Garmey

5CMO Consulting, Concord, CA, USA

Vincent Poon

1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Michael A Asensio

2GigaGen, San Carlos, CA, USA

Janice Lansita

4Alira Health, San Francisco, CA, USA

Kyle P Carter

2GigaGen, San Carlos, CA, USA

Ellen K Wagner

2GigaGen, San Carlos, CA, USA

Erica L Stone

2GigaGen, San Carlos, CA, USA